Rapid adoption of Veeva Commercial Cloud continues across industry for better multichannel customer engagement and greater commercial efficiency
Veeva Systems (NYSE: VEEV) announced today( May 8, 2017) that Bristol-Myers Squibb, a global biopharmaceutical company, will expand its adoption of Veeva Commercial Cloud in key markets outside of the U.S. The company will add Veeva CRM Events Management to better manage field events by streamlining approvals and reducing complexity in the process. Bristol-Myers Squibb will also leverage Veeva CRM Approved Email to support an integrated, tailored customer engagement experience.
Bristol-Myers Squibb is one of 22 life sciences companies that have adopted Veeva CRM Events Management since its release, quickly establishing it as a leading choice for companies to better orchestrate their customer engagement strategies.
“Customers continue to turn to Veeva for a unified suite of applications and data that deliver an orchestrated customer experience,” said Peter Gassner, founder and CEO of Veeva. “We’re excited to expand our relationship with Bristol-Myers Squibb and for the opportunity to further support the company’s mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.”
Veeva Commercial Cloud brings together customer data, compliant content, and multichannel engagement to eliminate commercial complexity and speed time to market. Life sciences companies use Veeva Commercial Cloud to deliver greater agility, better customer engagement, and improved efficiency throughout their commercial operations.
Additional Information
For more on Veeva Commercial Cloud, visit: veeva.com/CommercialCloud
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: twitter.com/veevasystems
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com.